These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7663667)

  • 1. [Reversible acute kidney failure during the treatment of ORL infections with niflumic acid].
    André JL; Hanesse B; Krier MJ; Trechot P
    Arch Pediatr; 1995 Jul; 2(7):699-700. PubMed ID: 7663667
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the use of the beta-morpholino-ethylic ester of niflumic acid in the treatment of non-surgical ORL infections in children. Apropos of 21 cases].
    Lauwers JP
    Rev Laryngol Otol Rhinol (Bord); 1979; 100(7-8):509-12. PubMed ID: 531386
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative trial by double-blind method of a niflumic acid derivative and oxyphenbutazone in pediatric O. R. L].
    Traissac L; Roche JC
    Rev Laryngol Otol Rhinol (Bord); 1979; 100(1-2):151-61. PubMed ID: 379941
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary study of the therapeutic action and tolerance of niflumic acid in pediatric otorhinolaryngology].
    Traissac L; Roche JC
    Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):317-21. PubMed ID: 897412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone].
    Tarantino V; Stura M; Cremonesi G
    Minerva Pediatr; 1985 Oct; 37(20):827-32. PubMed ID: 3912657
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neonatal renal insufficiency secondary to niflumic acid administration in pregnancy].
    Chevallier B; Baudet V; Doumaz Y; Renaud C; Costil J
    Arch Fr Pediatr; 1992 Nov; 49(9):841. PubMed ID: 1300978
    [No Abstract]   [Full Text] [Related]  

  • 7. [ORL infections. 10th consensus conference on anti-infectious therapeutics. Under the collaboration of the French Societies of Infectious Diseases, of ORL and of Pediatrics].
    Arch Pediatr; 1997 Feb; 4(2):188-94. PubMed ID: 9097834
    [No Abstract]   [Full Text] [Related]  

  • 8. [Beta-morpholino-ethyl ester of niflumic acid in infectious syndromes in children].
    Fournier JL
    Lille Med; 1977 Apr; 22(4 Suppl 1):286-9. PubMed ID: 875607
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of imipenem-cilastatin in acute ORL infections].
    Cerqua N; Tirelli GC; Piccirillo E
    Riv Eur Sci Med Farmacol; 1992; 14(6):409-10. PubMed ID: 1308610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of the beta-morpholino-ethylic ester of niflumic acid in children].
    Vanegroo A; Foulard M
    Lille Med; 1979 May; 24(5):418-20. PubMed ID: 502730
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activity of doxycycline in ORL infections].
    Rev Laryngol Otol Rhinol (Bord); 1984; 105(2):137-42. PubMed ID: 6377423
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of an anti-inflammatory agent, well tolerated by children, in the O.R.L. surgery].
    Morgon AH; Dubreuil C
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 Jun; 27(6):419-22. PubMed ID: 151729
    [No Abstract]   [Full Text] [Related]  

  • 13. [Injectable lincocin in the treatment of ORL infections].
    Muler H
    Ann Otolaryngol Chir Cervicofac; 1976 Jun; 93(6):443-6. PubMed ID: 984650
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics.
    Sturkenboom M; Nicolosi A; Cantarutti L; Mannino S; Picelli G; Scamarcia A; Giaquinto C;
    Pediatrics; 2005 Jul; 116(1):e26-33. PubMed ID: 15930187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A medium spectrum antibiotic in the therapy of ORL infections].
    López Rubio A; Estrada Velasco A; Ibarra J; Lazos O
    Prensa Med Mex; 1975; 40(7-8):256-8. PubMed ID: 768969
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clamoxyl in infectious pathology in the ORL field (apropos of 40 cases)].
    Traissac L
    Rev Laryngol Otol Rhinol (Bord); 1975; 96(1-2):93-8. PubMed ID: 1144965
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of the association of cloxacillin and ampicillin in ORL].
    Boniver R
    Acta Otorhinolaryngol Belg; 1973; 27(1):20-2. PubMed ID: 4697132
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of niflumic acid on chronic rheumatoid arthritis].
    Shichikawa K; Onoda T
    Ryumachi; 1976 May; 16(2):199-211. PubMed ID: 785616
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution of an anti-inflammatory agent in pedodontics].
    Justin J; Blocquel H; Baudin M
    Lille Med; 1980; 25(7):390-7. PubMed ID: 6448940
    [No Abstract]   [Full Text] [Related]  

  • 20. Niflumic acid in the management of rheumatoid and osteoarthritis.
    Tilve GH; Lengade JK; Bavadekar AV; Nair KG
    J Postgrad Med; 1976 Jul; 22(3):124-9. PubMed ID: 1032826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.